Authors:
THOMPSON J
CHENGAPPA KNR
GOOD CB
BAKER RW
KIEWE RP
BEZNER J
SCHOOLER NR
Citation: J. Thompson et al., HEPATITIS, HYPERGLYCEMIA, PLEURAL EFFUSION, EOSINOPHILIA, HEMATURIA AND PROTEINURIA OCCURRING EARLY IN CLOZAPINE TREATMENT, International clinical psychopharmacology, 13(2), 1998, pp. 95-98
Authors:
AHMED S
CHENGAPPA KNR
NAIDU VR
BAKER RW
PAREPALLY H
SCHOOLER NR
Citation: S. Ahmed et al., CLOZAPINE WITHDRAWAL EMERGENT DYSTONIAS AND DYSKINESIAS - A CASE SERIES, The Journal of clinical psychiatry, 59(9), 1998, pp. 472-477
Citation: Rw. Baker et Knr. Chengappa, GASTROESOPHAGEAL REFLUX AS A POSSIBLE RESULT OF CLOZAPINE TREATMENT, The Journal of clinical psychiatry, 59(5), 1998, pp. 257-257
Citation: J. Levine et Knr. Chengappa, 2ND THOUGHTS ABOUT CLOZAPINE AS A TREATMENT FOR NEUROLEPTIC-INDUCED AKATHISIA, The Journal of clinical psychiatry, 59(4), 1998, pp. 195-195
Authors:
CHENGAPPA KNR
SHETH S
BRAR JS
MARCUS S
PAREPALLY H
GOPALANI A
PALMER A
BAKER RW
SCHOOLER NR
Citation: Knr. Chengappa et al., A CLINICAL AUDIT OF THE FIRST 142 PATIENTS WHO RECEIVED RISPERIDONE AT A STATE PSYCHIATRIC-HOSPITAL, Psychopharmacology bulletin, 33(3), 1997, pp. 503-503
Authors:
BRAR JS
CHENGAPPA KNR
SANDMAN AR
KREINBROOK SB
SHETH SA
GANGULI R
Citation: Js. Brar et al., EFFECT OF CLOZAPINE ON NEGATIVE SYMPTOMS IN SCHIZOPHRENIC-PATIENTS WITH MINIMAL POSITIVE SYMPTOMS, Biological psychiatry, 41, 1997, pp. 244-244
Authors:
CHENGAPPA KNR
GOPALANI A
HAUGHT MK
MCCHESNEY K
BAKER RW
SCHOOLER NR
Citation: Knr. Chengappa et al., THE TREATMENT OF CLOZAPINE-ASSOCIATED AGRANULOCYTOSIS WITH GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF), Psychopharmacology bulletin, 32(1), 1996, pp. 111-121
Citation: Knr. Chengappa et al., THE SUCCESSFUL USE OF CLOZAPINE IN AMELIORATING SEVERE SELF-MUTILATION IN A PATIENT WITH BORDERLINE PERSONALITY-DISORDER, Journal of personality disorders, 9(1), 1995, pp. 76-82
Authors:
GANGULI R
BRAR JS
CHENGAPPA KNR
DELEO M
YANG ZW
SHURIN G
RABIN BS
Citation: R. Ganguli et al., MITOGEN-STIMULATED INTERLEUKIN-2 PRODUCTION IN NEVER-MEDICATED, FIRST-EPISODE SCHIZOPHRENIC-PATIENTS - THE INFLUENCE OF AGE AT ONSET AND NEGATIVE SYMPTOMS, Archives of general psychiatry, 52(8), 1995, pp. 668-672
Citation: Rw. Baker et Knr. Chengappa, FURTHER STUDY OF NEUROLEPTIC MALIGNANT SYNDROME, The American journal of psychiatry, 152(12), 1995, pp. 1831-1831
Authors:
GANGULI R
YANG ZW
CHENGAPPA KNR
BRAR JS
SHURIN G
RABIN BS
Citation: R. Ganguli et al., DECREASED MITOGEN-STIMULATED IL-2 PRODUCTION IN FIRST EPISODE DRUG-NAIVE SCHIZOPHRENIC-PATIENTS, Schizophrenia research, 11(2), 1994, pp. 128-128
Authors:
GANGULI R
YANG ZW
SHURIN G
CHENGAPPA KNR
BRAR JS
GUBBI AV
RABIN BS
Citation: R. Ganguli et al., SERUM INTERLEUKIN-6 CONCENTRATION IN SCHIZOPHRENIA - ELEVATION ASSOCIATED WITH DURATION OF ILLNESS, Psychiatry research, 51(1), 1994, pp. 1-10
Citation: Knr. Chengappa et al., THE PREVALENCE OF AKATHISIA IN PATIENTS RECEIVING STABLE DOSES OF CLOZAPINE, The Journal of clinical psychiatry, 55(4), 1994, pp. 142-145
Authors:
YANG ZW
CHENGAPPA KNR
SHURIN G
BRAR JS
RABIN BS
GUBBI AV
GANGULI R
Citation: Zw. Yang et al., AN ASSOCIATION BETWEEN ANTI-HIPPOCAMPAL ANTIBODY CONCENTRATION AND LYMPHOCYTE-PRODUCTION OF IL-2 IN PATIENTS WITH SCHIZOPHRENIA, Psychological medicine, 24(2), 1994, pp. 449-455
Authors:
CHENGAPPA KNR
YANG ZW
SCHURIN G
FAROOQUI SM
RABIN BS
GANGULI R
Citation: Knr. Chengappa et al., ANTIBODIES TO D-2 RECEPTOR IN NEUROLEPTIC-NAIVE SCHIZOPHRENIC-PATIENTS, Biological psychiatry, 33(6A), 1993, pp. 97-97